Case 1 Background 1024x716

Achieving meaningful HCP reappraisal without field support

A chronic insomnia brand tasked ADG to help them challenge the way GPs think about the diagnosis and treatment of insomnia and to drive the launch of new science (a sleep/wake system) and treatment options. Within the first two weeks of launch 1,740 GPs had viewed the brand eDetails.

View

Dreamstime S 56481319

How has COVID-19 changed GP and pharmaceutical field staff engagement?

With the sudden and dramatic impact of COVID-19, a survey of GPs and their contact with pharmaceutical field staff during the pandemic reveals a massive drop in face-to-face engagement. The joint Australian Doctor Group and Medicines Australia poll was sent out in mid-May and attracted almost 400 responders. It shows prior to the pandemic half

View

Leading Brands Doctors Know Trust

COVID-19: Is it time for governments to start a conversation with GPs?

As Australia enters a new phase of its COVID-19 journey, governments have an increasing opportunity to engage in a two-way conversation with GPs; not only about the virus itself but also about ensuring their patients don’t ignore their general health during the pandemic.  GPs are generally satisfied with the COVID-19 information they have received up to now, according to a survey of AusDoc.PLUS readers1. But a big gripe is that different information sources

View

Dreamstime L 59930798

ADG’s response to COVID-19

How Australian Doctor Group responded to COVID-19 — keeping GPs and the healthcare community informed through Australia's #1 independent medical platform during the pandemic.

View

Prime Awards 2019 Winners The Complete List

PRIME Awards 2019 winners: the complete list

The 15th PRIME Awards celebrated excellence in Australian healthcare communications. See the complete winners list from pharma, media and health agencies at Sydney's Four Seasons Hotel.

View